[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614604":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":24,"responsibleParty":49,"collaborators":52,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":58,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Northumbria University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Parkinson's Disease (PD)",null,"People with a clinical diagnosis of Parkinson's Disease will be recruited to participate within the study. All participants must fit within the described eligibility criteria.\n\nWithin the verification and analytical validation phase 30 people with Parkinson's will be recruited and within clinical validation 60 individuals will be recruited.",[13],{"name":14,"affiliation":5,"role":15},"Rodrigo Vitorio, PhD","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Gabriella R Gatti, BSc","CONTACT","01912273343","gabriella.gatti@northumbria.ac.uk",{"name":14,"role":19,"phone":20,"phoneExt":10,"email":23},"rodrigo.vitorio@northumbria.ac.uk",[25],{"facility":5,"status":26,"city":27,"state":10,"zip":10,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Newcastle upon Tyne","United Kingdom","UK",{"type":31,"coordinates":32},"Point",[33,34],-1.61396,54.97328,{"lat":34,"lon":33},[37,38,39,42,43,45,47],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},{"name":14,"role":19,"phone":20,"phoneExt":10,"email":23},{"name":40,"role":41,"phone":10,"phoneExt":10,"email":10},"Gabriella R Gatti, Bsc","SUB_INVESTIGATOR",{"name":14,"role":15,"phone":10,"phoneExt":10,"email":10},{"name":44,"role":41,"phone":10,"phoneExt":10,"email":10},"Rosie Morris, PhD",{"name":46,"role":41,"phone":10,"phoneExt":10,"email":10},"Alan Godfrey, PhD",{"name":48,"role":41,"phone":10,"phoneExt":10,"email":10},"Samuel Stuart, PhD",{"type":15,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"GabriellaGatti","Postgraduate Researcher",[53],{"name":54,"class":55},"DANU Sports Ltd","UNKNOWN","100614604","objective-mobility-assessment-using-wearable-technology-for-clinical-application-in-parkinsons-disease-from-validation-to-fall-prediction-100614604",false,"NCT07281755","Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction","Inclusion Criteria:\n\n* Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.\n* Hoehn \\& Yahr stages I-III\n* Able to attend Northumbria University, Newcastle Upon Tyne for study visits\n* Able to walk and stand unassisted for a minimum of 2-minutes\n\nExclusion Criteria:\n\n* History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)\n* Montreal Cognitive Assessment (MoCA) score \\\u003C 21\n* Injury to the lower extremities within the past 6-weeks.","ALL","50 Years",{"count":65,"type":66},60,"ESTIMATED","OBSERVATIONAL","The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.",[70],"Parkinson Disease(PD)",[72,73,74,75,76,77],"DANU","Wearable Electronic Devices","Gait Analysis","Validity and Reliability","Mobility Assessment","Smart Socks","2026-02-11",{"date":80,"type":81},"2026-02-12","ACTUAL",{"date":83,"type":81},"2025-08-08",{"date":85,"type":66},"2027-09",{"name":5,"class":6},1]